Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series.
Bond KA, Dendle C, Guy S, Slavin MA, Smibert O, Ibrahim N, Kinsella PM, Morrissey CO, Moso MA, Sasadeusz JJ. Bond KA, et al. Open Forum Infect Dis. 2024 Aug 7;11(8):ofae449. doi: 10.1093/ofid/ofae449. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39189033 Free PMC article.
Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia.
Kinsella P, Moso M, Martin G, Karapangiotidis T, Karamalakis D, Nicholson S, Batty M, Jackson K, Marsland M, Thomson T, Manoharan L, O'brien H, Friedman ND, Bond K, Williamson DA, Lim CK. Kinsella P, et al. J Clin Virol. 2023 Nov;168:105580. doi: 10.1016/j.jcv.2023.105580. Epub 2023 Sep 9. J Clin Virol. 2023. PMID: 37717487 Free article.
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study.
Muhi S, Tayler N, Hoang T, Ballard SA, Graham M, Rojek A, Kwong JC, Trubiano JA, Smibert O, Drewett G, James F, Gardiner E, Chea S, Isles N, Sait M, Pasricha S, Taiaroa G, McAuley J, Williams E, Gibney KB, Stinear TP, Bond K, Lewin SR, Putland M, Howden BP, Williamson DA. Muhi S, et al. Lancet Reg Health West Pac. 2021 Apr;9:100115. doi: 10.1016/j.lanwpc.2021.100115. Epub 2021 Mar 2. Lancet Reg Health West Pac. 2021. PMID: 33937887 Free PMC article.
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.
Nguyen THO, Rowntree LC, Allen LF, Chua BY, Kedzierski L, Lim C, Lasica M, Tennakoon GS, Saunders NR, Crane M, Chee L, Seymour JF, Anderson MA, Whitechurch A, Clemens EB, Zhang W, Chang SY, Habel JR, Jia X, McQuilten HA, Minervina AA, Pogorelyy MV, Chaurasia P, Petersen J, Menon T, Hensen L, Neil JA, Mordant FL, Tan HX, Cabug AF, Wheatley AK, Kent SJ, Subbarao K, Karapanagiotidis T, Huang H, Vo LK, Cain NL, Nicholson S, Krammer F, Gibney G, James F, Trevillyan JM, Trubiano JA, Mitchell J, Christensen B, Bond KA, Williamson DA, Rossjohn J, Crawford JC, Thomas PG, Thursky KA, Slavin MA, Tam CS, Teh BW, Kedzierska K. Nguyen THO, et al. Among authors: bond ka. Cell Rep Med. 2023 Apr 18;4(4):101017. doi: 10.1016/j.xcrm.2023.101017. Epub 2023 Mar 27. Cell Rep Med. 2023. PMID: 37030296 Free PMC article.
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S, Karapanagiotidis T, Khvorov A, Douros C, Mordant F, Bond K, Druce J, Williamson DA, Purcell D, Lewin SR, Sullivan S, Subbarao K, Catton M. Nicholson S, et al. Open Forum Infect Dis. 2021 May 10;8(7):ofab239. doi: 10.1093/ofid/ofab239. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34258311 Free PMC article.
46 results